CG Oncology (CGON) Current Assets (2023 - 2026)

CG Oncology (CGON) has 4 years of Current Assets data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 57.18% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 57.18% YoY), and the FY2025 full-year result was $759.5 million, up 0.7% from the prior year.
• Current Assets for Q1 2026 stood at $1.1 billion, up from $759.5 million in the prior quarter.
• Across five years, Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $194.1 million in Q4 2023.
• The 4-year median for Current Assets is $684.4 million (2025), against an average of $657.5 million.
• The widest annual swing landed in 2024, when Current Assets jumped 288.52%; it then increased 0.7% in 2025.
• A 4-year view of Current Assets shows it stood at $194.1 million in 2023, then surged by 288.52% to $754.2 million in 2024, then increased by 0.7% to $759.5 million in 2025, then soared by 45.12% to $1.1 billion in 2026.
• The last three Current Assets figures came in at $1.1 billion (Q1 2026), $759.5 million (Q4 2025), and $695.8 million (Q3 2025), per Business Quant data.

Peer Comparison